Shift In Drug Approval Process At FDA Under Trump? | WVIA

Shift In Drug Approval Process At FDA Under Trump?

Last Updated by NPR on

This week, the FDA did something rare: it reversed itself, and said it would no longer require further study of a drug for a rare disease. Instead, the FDA said the drug company could go ahead and seek approval of the drug with just the data from previous clinical trials. There have been other instances in recent months of the FDA allowing drugs to move through the approval process more quickly.

Adam Feuerstein (@adamfeuerstein), national biotech columnist for STAT, joins Here & Now‘s Meghna Chakrabarti to look at whether there’s a shift in how drugs are being regulated and approved at the FDA under President Trump and FDA Commissioner Scott Gottlieb.

Copyright 2017 NPR. To see more, visit http://www.npr.org/.

pbs.pngnpr.pngpbskids.png
listenlive_fulllength.jpg cove_spacer.png
Now Playing on WVIA-FM

        

nprnews5.jpg

More Than Twice As Many Women Are Running For Congress In 2018 Compared To 2016

Donald Trump is fueling many women's desire to run for office in 2018 — in the words of one analyst, he's "the gift...

How Long Are You Contagious With The Flu?

Finally getting out from under the flu? Just because you're feeling better doesn't mean you can't get other people...

The Father Of The Internet Sees His Invention Reflected Back Through A 'Black Mirror'

The titans of Silicon Valley have a grand vision of the future. But they have a tendency to miss the downside of...

Trump Endorses Romney For U.S. Senate, But Does It Signal Détente?

Pundits have speculated that the famously strained relationship between the president and the former presidential...

Rules For 2018 Aim To Speed Up How Long It Takes To Play A MLB Game

Among the changes, Major League Baseball will impose stricter limits on mound visits and commercial breaks will be...

healthybites_sidebar2.png reserve3.png

playtimepad_box.png

artscene_header.png